According to Roche, the HER2 (4B5) clone consistently achieves high proficiency assessment scores against other clones. "FDA ...

His work in pathology is not only influential in clinical practice but also in pioneering research, specifically in liver and ...

US FDA approves Roche’s companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with Ziihera: Tucson, Arizona Tuesday, November ...

The global radiofrequency balloon catheter market, valued at USD 50 billion in 2022, is set for a remarkable growth ...

Sonny White was diagnosed with biliary atresia shortly after he was born. Sandy Flash donated a portion of her liver to help ...

Global Bispecific Antibody Is Expected To Surpass US$ 40 Billion By 2029 Says Kuick ResearchDelhi, Nov. 25, 2024 (GLOBE ...

With two decisions originally scheduled for this week already announced, including BridgeBio's approval in ATTR-CM, the ...

“Aside from some uncomfortableness, she has been doing well the past couple of days, which is why they were comfortable ...

The United States Food and Drug Administration has approved the use of a cancer treatment antibody originally developed by ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Conversely, variants associated with increased risk of atrial fibrillation (GORAB-PRRX1) and biliary disorders (ABCC2) were ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii) for the treatment of adults with previously treated, unresectable or metastatic HER2-positive ...